← Leaderboards
Teresa P Dilorenzo
Albert Einstein College Of Medicine
$11,494,696
Attributed
$14,645,873
Total exposure
13
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,645,873 · 13
By mechanism
R01$12,286,344 · 6
R21$895,761 · 2
P30$737,952 · 2
R56$282,200 · 1
P01$276,616 · 1
R03$167,000 · 1
Top collaborators
- Steven C. Almo10 shared
- Anthony Purcell2 shared
Most similar at Albert Einstein College Of Medicine
Same institution · by research overlap
- Jennifer Schloss$197,613
- Anthony Purcell$749,954
Others in their field
Top investigators on “Islet”
- Mark A Magnuson · Vanderbilt University$65,807,651
- Klaus H. Kaestner · University Of Pennsylvania$57,769,062
- Jeffrey P Krischer · University Of South Florida$55,786,141
- Joyce Carol Niland · City Of Hope/Beckman Research Institute$53,941,128
- William R Clarke · University Of Iowa$48,959,550
- Ali Naji · University Of Pennsylvania$44,286,634
Research focus
IsletCellsPeptidesT-LymphocyteAntigensMouse ModelInsulin-Dependent Diabetes MellitusBeta CellInsulinMediatingCd8b1 GeneIslets Of LangerhansBaseInbred Nod MiceReagentAutoimmune DiseasesMonitorAutoimmunityAutoreactive T CellAutoantigensCharacteristicsPathogenMorbidity - Disease RateDendritic Cells
Grant awards (45)
Identification and characterization of the class I and class II MHC molecules of the Syrian hamster to enable advanced studies of T cell immunity$486,200
R21 · FY2025 · AI · contact PI
The "dark immunopeptidome" as a source of CD8 T cell epitopes in type 1 diabetes$586,996
R01 · FY2024 · DK · contact PI
Einstein Mount Sinai Diabetes Research Center$147,924
P30 · FY2024 · DK · contact PI
The "dark immunopeptidome" as a source of CD8 T cell epitopes in type 1 diabetes$616,624
R01 · FY2023 · DK · contact PI
Einstein Mount Sinai Diabetes Research Center$147,924
P30 · FY2023 · DK · contact PI
Structural, functional, and mechanistic anlaysis of autoreactive CD8 T cells$715,797
R01 · FY2022 · AI · contact PI
Einstein Mount Sinai Diabetes Research Center$147,924
P30 · FY2022 · DK · contact PI
Structural, functional, and mechanistic anlaysis of autoreactive CD8 T cells$715,797
R01 · FY2021 · AI · contact PI
Einstein Mount Sinai Diabetes Research Center$147,924
P30 · FY2021 · DK · contact PI
Structural, functional, and mechanistic anlaysis of autoreactive CD8 T cells$715,797
R01 · FY2020 · AI · contact PI
An immunotherapeutic strategy for the induction and stabilization of remission in type 1 diabetes$501,000
R01 · FY2020 · DK · contact PI
Einstein Mount Sinai Diabetes Research Center$146,256
P30 · FY2020 · DK · contact PI
Structural, functional, and mechanistic anlaysis of autoreactive CD8 T cells$716,287
R01 · FY2019 · AI · contact PI
An immunotherapeutic strategy for the induction and stabilization of remission in type 1 diabetes$501,000
R01 · FY2019 · DK · contact PI
An immunotherapeutic strategy for the induction and stabilization of remission in type 1 diabetes$415,917
R01 · FY2018 · DK · contact PI
Structural, functional, and mechanistic anlaysis of autoreactive CD8 T cells$367,866
R01 · FY2018 · AI · contact PI
Structural, functional, and mechanistic anlaysis of autoreactive CD8 T cells$364,190
R01 · FY2018 · AI · contact PI
An immunotherapeutic strategy for the induction and stabilization of remission in type 1 diabetes$85,083
R01 · FY2018 · DK · contact PI
CD8 T Cell Epitope Mapping Using Mice Expressing HLA-A2 and a Human Autoantigen$83,500
R03 · FY2016 · AI · contact PI
T Cell Tolerance by DEC-205-mediated Islet Antigen Delivery to Dendritic Cells$364,146
R01 · FY2015 · DK · contact PI
Antigens Recognized by CD8+ T Cells in Type 1 Diabetes$245,176
R01 · FY2015 · DK · contact PI
Antigens Recognized by CD8+ T Cells in Type 1 Diabetes$81,726
R01 · FY2015 · DK · contact PI
CD8 T Cell Epitope Mapping Using Mice Expressing HLA-A2 and a Human Autoantigen$48,709
R03 · FY2015 · AI · contact PI
CD8 T Cell Epitope Mapping Using Mice Expressing HLA-A2 and a Human Autoantigen$34,791
R03 · FY2015 · AI · contact PI
T Cell Tolerance by DEC-205-mediated Islet Antigen Delivery to Dendritic Cells$364,146
R01 · FY2014 · DK · contact PI
Antigens Recognized by CD8+ T Cells in Type 1 Diabetes$326,903
R01 · FY2014 · DK · contact PI
T Cell Tolerance by DEC-205-mediated Islet Antigen Delivery to Dendritic Cells$351,387
R01 · FY2013 · DK · contact PI
Antigens Recognized by CD8+ T Cells in Type 1 Diabetes$315,461
R01 · FY2013 · DK · contact PI
Antigens Recognized by CD8+ T Cells in Type 1 Diabetes$380,379
R01 · FY2012 · DK · contact PI
T Cell Tolerance by DEC-205-mediated Islet Antigen Delivery to Dendritic Cells$366,149
R01 · FY2012 · DK · contact PI
T Cell Tolerance by DEC-205-mediated Islet Antigen Delivery to Dendritic Cells$374,726
R01 · FY2011 · DK · contact PI
Antigens Recognized by CD8+ T Cells in Type 1 Diabetes$304,874
R01 · FY2010 · DK · contact PI
T Cell Tolerance by DEC-205-mediated Islet Antigen Delivery to Dendritic Cells$282,200
R56 · FY2010 · AI · contact PI
Antigens Recognized by CD8+ T Cells in Type 1 Diabetes$307,953
R01 · FY2009 · DK · contact PI
Antigens Recognized by CD8+ T Cells in Type 1 Diabetes$307,953
R01 · FY2008 · DK · contact PI
Antigens Recognized by CD8+ T Cells in Type 1 Diabetes$314,238
R01 · FY2007 · DK · contact PI
Synthetic T Cell Ligands in the Study of Type 1 Diabetes$276,616
P01 · FY2007 · DK · contact PI
CD8 T Cell Reactivity to IGRP as an Autoimmunity Marker in Type 1 Diabetes$185,461
R21 · FY2007 · DK · contact PI
Antigens Recognized by CD8+ T Cells in Type 1 Diabetes$287,013
R01 · FY2006 · DK · contact PI
CD8 T Cell Reactivity to IGRP as an Autoimmunity Marker in Type 1 Diabetes$224,100
R21 · FY2006 · DK · contact PI
Antigens Recognized by CD8+ T Cells in Type 1 Diabetes$293,920
R01 · FY2005 · DK
Prevention of Diabetes with Lipid Immunomodulators$205,000
R01 · FY2005 · AI
Antigens Recognized by CD8+ T Cells in Type 1 Diabetes$293,920
R01 · FY2004 · DK
Prevention of Diabetes with Lipid Immunomodulators$205,000
R01 · FY2004 · AI
Antigens Recognized by CD8+ T Cells in Type 1 Diabetes$293,920
R01 · FY2003 · DK